2018 US Interchange Presentations

Thank you for attending the 2018 US Interchange. You will find a link to each of the presentation slides from the event below.

Note: Presentations are subject to copyright and may not be used without written consent of CDISC or its affiliates.

 

Session 1: Opening Plenary and First Keynote Address

Opening Remarks
David R. Bobbitt, CDISC President and CEO; and Stephen Pyke, GSK, CDISC Board Chair

Keynote Presentation - CDISC Standards in the Real World
Jonathan Chainey, Roche

State of the CDISC Union - Bringing Clarity to Data (Standards Overview Video)
David R. Bobbitt, CDISC President and CEO

Session 2: Evolving Standards

Evolution of the CDISC Standards
Peter Van Reusel, CDISC

Changing Data and Metadata Exchange in Clinical Research
Sam Hume, CDISC

Semantic Technology and Linked Data for Clinical Research Standards
Frederik Malfait, Nurocor

Session 3: Second Keynote Address

Precisely Practicing Medicine from 700 Trillion Points of Clinical and Clinical Trials Data
Atul Butte, MD, PhD, Priscilla Chan and Mark Zuckerberg Distinguished Professor, University of California San Francisco

Session 4, Track A: Linking to Other Standards and Dictionaries

WHODrug, with a Focus on the New B3/C3 Formats
Malin Jakobsson, Uppsala Monitoring Centre

The ADaM Universe of Mapping Specs, Datasets, Define-XML and Beyond
Valerie Williams, ICON Clinical Research

Delivering LOINC Codes in the Future: Bridging Gaps within the Clinical Lifecycle (Paper)
Diane Piper, Shire

Session 4, Track B: Creating Clarity

Myths and Truths: The World of Standards, Pre/post Coordinating Controlled Terminology, LOINC, UCUM and Standardized Lab Units
Kit Howard and Bess Leroy, CDISC

CDISC Standards Updates: Preview of 2019
Diane Wold, CDISC

Who to Ask about Submission Questions
Helena Sviglin, FDA-CDER and Diane Wold, CDISC

Session 4, Track C: Toward B2E Automation: Data Warehousing

A Practical Approach to Automating End to End Standards
Steve Kirby, Reata Pharmaceuticals Inc. and Mario Widel, Covance

Maximizing the Use of Patient Data Warehouse via Visual Analytics (Paper)
Simson Alex and Sandy Lei, Johnson & Johnson

What’s New in SHARE 2: Featuring a New Model, API, and Content​
Anthony Chow, CDISC

Session 5, Track A: Implementation: Beginning to End (B2E)

Enforcing Standards in an Organization: A Practical 5-Step Approach (Paper)
Priscilla Gathoni and Dany Guerendo Christian, AstraZeneca

Developing, Implementing and Governing End-to-End Data Standards at Gilead
Dhananjay Chhatre, Gilead

Data Transfer System from Electronic Medical Record used for Clinical Trials
Yoshihiro Aoyagi, National Cancer Center Hospital East, Japan

Session 5, Track B: Newcomers Session: Overview of CDISC Standards

CDASH and SDTM, and Why You Need Both
Kit Howard, CDISC

Controlled Terminology/Questionnaires, Ratings and Scales
Erin Muhlbradt, National Cancer Institute - Enterprise Vocabulary Service [C]

ODM and Extensions
Sally Cassells, Next Step Clinical Systems

Session 5, Track C: Toward B2E Automation: Machine Learning

Machine Learning Approach to SDTM Mapping
Sam Tomioka, Sunovion Pharmaceuticals

Automated Annotation of a Blank CRF Using ML/NLP
Saranga Ram, Ratilan Technologies, Inc. and Eric Weising, Symbiance

Challenges in Mapping Specific Autologous CAR-T Therapy Data into SDTM – A Case Study​ (Paper)
Mark Mendenhall and Jinlin Wang, Kite Pharma, a Gilead Company

Session 6, Track A: Implementation: Organization

Raising the Bar for Data Standardization: How to Ensure Your Submission Data Supports the Automated Review Process at FDA and PMDA
Max Kanevsky and Sergiy Sirichenko, Pinnacle 21

Challenges of CDISC Implementation and Submission to both Japan PMDA and FDA (Paper)
Yumiko Asami, Daiichi Sankyo Co., Ltd. and Janet Reich, Amgen Inc.

Where is my GPS?: A Process Roadmap for Overcoming Data Integration Humps (Paper)
Dorothy Dlamini, Bayer Pharmaceutical AG

Session 6, Track B: Newcomers Session: Overview of CDISC Standards (continued)

ADaM Overview
Sandra Minjoe, PRA Health Sciences

Data Exchange Standards (RDF/OWL/XML)
Sam Hume, CDISC

Introduction to TA Standards, Review of Published TA standards
Jon Neville, CDISC

Session 6, Track C: Implementation: Tooling and Define-XML

How the Define-XML Framework Can Help you Manage Begin-to-End Data Traceability in an MDR (Paper)
Judith Goud, Nurocor

Visual Define-XML Editor (Paper)
Dmitry Kolosov, Independent

Do’s and Don’ts of Define-XML
David Roulstone, Pinnacle 21

Session 7, Track A: Implementation: Pre-Clinical Standards

Implementing SEND at Pfizer - Challenges and How They Were Overcome
Keli Arnold, Christopher Eley, and Leslie Lorello, Pfizer

The Making of SEND: Delivery Through Inter-Organizational Collaboration
Lou Ann Kramer, CDISC and William Houser, FDA

Preparing for SEND
Roman Radelicki, SGS

Session 7, Track B: New Implementation Use Cases: Observational/Post-Marketing Studies

Application of the SDTM Standard to a Public Health Dataset
Thomas Forrester, Frontier Science Technology and Research Foundation

Challenges and Opportunities: Using CDISC Standards for Observational Data
Jon Neville, CDISC

Data Utilization in RWD in Public Health and CDISC Standards (Paper)
Hiroshi Mizushima and Satoshi Ueno, National Institute of Public Health, Japan

Session 7, Track C: Implementation: Analysis and Validation

A Look at What Is Coming: CDISC Conformance Rules for ADaMIG v1.0 and ADaMIG v1.1 (Paper)
Trevor Mankus, PRA Health Sciences and Alyssa Wittle, Covance

Incremental Changes: ADaMIG v1.2 Update (Paper)
Nancy Brucken, Syneos Health and Deb Goodfellow, Covance

An Anatomy of Efficacy Analysis Datasets in Oncology (Paper)
Ke Xiao, Boehringer-Ingelheim

Session 8: Regulatory Session

PMDA: Yuki Ando; FDA: Ta-Jen Chen, Eileen Navarro Almario and Vaishali Popat

Session 9: Roundtable Discussion

PMDA: Yuki Ando; FDA: Ron Fitzmartin, Lisa Lin, Lilliam Rosario, Helena Sviglin and Jack Zhang; Jonathan Chainey, Roche; Paul Slagle, Syneos Health; Gary Walker, IQVIA and Peter Van Reusel, CDISC